Search results

  1. J

    Johnny Boufarhat—mystery illness

    TECH SAVVY ‘Mystery sickness’ left me laid up in bed & on my computer…now I’ve I turned my skill into £4.5BILLION tech firm He is now third in the 'young' rich list, with only the Duke of Westminster and Lady Wellesley ahead of him...
  2. J

    Encephalitis lethargica - The forgotten epidemic

    Why wasn’t there any post-Covid EL? Why haven’t we heard of anyone being diagnosed with EL in the last twenty years or so?
  3. J

    Impacts of the 2024 change in US government on ME/CFS and Long Covid

    Important read on Jay Bhattacharya's NIH nomination and why it's very bad. (And if you think the author is a "leftist," you are so barking up the wrong tree. https://socialimpurity.substack.com/p/lets-talk-about-merit-again
  4. J

    USA: Mount Sinai PACS clinic and Dr David Putrino

    Spitting into the wind…
  5. J

    Closed 2022 Pilot study in Norway - Daratumumab in ME/CFS

    Does anyone know how to score the DSQ SF test? https://www.leonardjason.com/wp-content/uploads/2021/05/DSQ-SF.pdf ETA: guessing that you add together the scores for the first 14 questions in the frequency and severity columns.
  6. J

    Norketotifen

    Ugh. It’s an antihistamine.
  7. J

    Upadacitinib (rinvoq)--could it reduce fatigue in ME/CFS?

    Observation, NOT a judgement. With respect to the HR remission account, if the patient was so severe, and frequently couldn’t eat, speak or move, how did they manage to have and raise 2 kids during the time they had MECFS?
  8. J

    [Case Report] Treatment of Long Covid with Enoxaparin, 2025, Wright, Kell, Pretorius, Putrino

    “Informed consent was obtained from the patient to publish this case report.”
  9. J

    Closed 2022 Pilot study in Norway - Daratumumab in ME/CFS

    Seems like there are more adverse reactions with IV than subQ https://www.pharmacytimes.com/view/pharmacy-department-driven-initiative-to-reduce-subcutaneous-daratumumab-observation-time
  10. J

    Closed 2022 Pilot study in Norway - Daratumumab in ME/CFS

    @Jonathan Edwards or anyone else. Do we know why 4 injections are needed? And why the 2 week interval? Since Dara is really expensive, if patients could get away with 3 injections (and get enough cd38 depletion), it would really be a cost saver.
  11. J

    Closed 2022 Pilot study in Norway - Daratumumab in ME/CFS

    Yes. Ingrid is not in the same group as Jonas. Ingrid did her Ph.D. in Bergen with Fluge’s group. The only knock on Ingrid is that she doesn’t respond to emails even from Norwegians.
  12. J

    Should we change our name: 'ME/CFS Skeptic'?

    I think you should change it. ME/CFS [research] update(s) ME/CFS research highlights or digest, abstracts
  13. J

    Closed 2022 Pilot study in Norway - Daratumumab in ME/CFS

    I thought high IGG meant a more severe disease state, therefore harder to treat?
  14. J

    Closed 2022 Pilot study in Norway - Daratumumab in ME/CFS

    @Jonathan Edwards Do these data potentially change your mind about Daratumumab being a viable treatment for MECFS? Also why is it that people with lower initial IGG respond better to both dara and cyclo? I thought that high IGG potentially indicated autoimmune diseases involvement. So...
  15. J

    Closed 2022 Pilot study in Norway - Daratumumab in ME/CFS

    Subcutaneous dara is dara plus hyaluronidase-FIHJ. Does anyone what FIHJ stands for? Thanks.
  16. J

    Closed 2022 Pilot study in Norway - Daratumumab in ME/CFS

    Some good news on the dara trial is released. They show 3 patients. They also show steps, which I like a lot more than the SPF PF score. The two responders had lower initial IGG levels, just like the cyclo trial. @Jonathan Edwards How come the dara didn’t lower IGG much in patient 2?
  17. J

    Aripiprazole as protector against COVID-19 mortality Munecas et al 2024

    I’m sorry that you feel that you’ve been harmed by high dose Abilify. However many thousands of ME/CFS patients have benefited, some very substantially, from low dose Abilify.
  18. J

    Best US Charities to Donate to?

    But this is more of advocacy rather than research, which is fine, if that’s the goal of your contribution. I gave to Solve at one point but got the heebee-jeebees based on their funding of questionable research.
  19. J

    On how to test more drugs, 2024, Teslo & Chertman

    Haven’t read yet… https://www.writingruxandrabio.com/p/on-clinical-trial-abundance
Back
Top Bottom